Genetic polymorphism (sequence variations) of foreign substance- metabolizing enzymes and their significance in environmental medicine: Statement of the Commission for "Methods and Quality Assurance in Environmental Medicine";Genetische Polymorphismen (Sequenzvariationen) von Fremdstoff- metabolisierenden Enzymen und ihre Bedeutung in der Umweltmedizin Mitteilung der Kommission "Methoden und Qualitätssicherung in der Umweltmedizin"

Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz

Volumn 47, Issue 11, 2004, Pages 1115-1123

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ARYLAMINE ACETYLTRANSFERASE; CYTOCHROME P450; GLUTATHIONE TRANSFERASE; ISOENZYME; N ACETYLTRANSFERASE 1; N-ACETYLTRANSFERASE 1;

AMINO ACID SUBSTITUTION; CLINICAL PRACTICE; CONFERENCE PAPER; CONSENSUS DEVELOPMENT; ENVIRONMENTAL DISEASE; ENVIRONMENTAL HEALTH; ENZYMOLOGY; ETHICS; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC SCREENING; GENETICS; GERMANY; HUMAN; METABOLISM; METHODOLOGY; MUTATION; POLLUTANT; PRACTICE GUIDELINE; RISK ASSESSMENT; RISK FACTOR; SEQUENCE ANALYSIS; STANDARD;

AMINO ACID SUBSTITUTION; ARYLAMINE N-ACETYLTRANSFERASE; CYTOCHROME P-450 ENZYME SYSTEM; ENVIRONMENTAL ILLNESS; ENVIRONMENTAL MEDICINE; ENVIRONMENTAL POLLUTANTS; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; GERMANY; GLUTATHIONE TRANSFERASE; HUMANS; ISOENZYMES; MUTATION; PHYSICIAN'S PRACTICE PATTERNS; POLYMORPHISM, GENETIC; PRACTICE GUIDELINES; RISK ASSESSMENT; RISK FACTORS; SEQUENCE ANALYSIS, PROTEIN;

EID: 14644397674     PISSN: 14369990     EISSN: 14371588     Source Type: Journal    
DOI: 10.1007/s00103-004-0931-3     Document Type: Conference Paper

References (51)

1. Lander ES, Linton LM, Birren et al. (2001) Initial sequencing and analysis of the human genome. Nature 409:860-921
2. Seidegard J, Vorachek WR, Pero R.W., Pearson W.R. (1988) Hereditary differences in the expression of the human glutathione transferase active on trans-stilbene oxide are due to a gene deletion. Proc Natl Acad Sci USA 85:7293-7297
3. Pemble SE, Schroeder KR, Spencer SR et al. (1994) Human glutathione S-transferase Theta (GSTT1): cDNA cloning and the characterization of a genetic polymorphism. Biochem J 300:271-275
4. Angerer J, Müller M (2004) Analyses of hazardous substances in biological material. Special issue: marker of susceptibility. Wiley-VCH, Weinheim
5. Schulz T (2003) Genetische Polymorphismen (Sequenzvariationen) von Fremdstoff-metabolisieren-den Enzymen und ihre Bedeutung in der Umweltmedizin. Handbuch für Umweltmedizin, 27. Erg. Lfg. 10/03, Sektion III-2.2.11,1-20. Ecomed, Lands-berg/Lech
6. Nebert DW (2000) Suggestions for the nomenclature of human alleles: relevance to ecogenetics, pharmacogenetics and molecular epidemiology. Pharmacogenetics 10:279-290
7. Bartsch H (2000) Studies on biomarkers in cancer etiology and prevention: a summary and challenge of 20 years of interdisciplinary research. Mutat Res 462:255-279
8. Wrighton SA, Stevens J.C. (1992) The human hepatic cytochromes P450 involved in drug metabolism. Crit Rev Toxicol 22:1-21
9. Hayes JD, Pulford D.J. (1995) The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit Rev Bio-chem Mol Biol 30:445-600
10. Dekant W, Koob M, Henschler D. (1990) Metabolism of trichloroethene in vivo and in vitro evidence for activation by glutathione conjugation. Chem Biol Interact 73:89-101
11. Sherrat PJ, Hayes J.D. (2002) Glutathione S-transfera-ses. In: Ioannides C (ed) Enzyme systems that metabolise drugs and other xenobiotics. Wiley, New York Weinheim, pp 319-352
12. Garte S, Gaspari L, Alexandrie AK et al. (2001) Metabolic gene polymorphism frequencies in control populations. Cancer Epidemiol Biomarkers Prev 10:1239-1248
13. Engel LS, Taioli E, Pfeiffer R et al. (2002) Pooled analysis and meta-analysis of glutathione S-transfer-ase M1 and bladder cancer: a HuGE review. Am J Epidemiol 156:95-109
14. Geisler SA, Olshan A.F. (2001) GSTM1, GSTT1, and the risk of squamous cell carcinoma of the head and neck a mini-HuGE review. Am J Epidemiol 154:95-105
15. Cotton SC, Sharp L, Little J., Brockton N. (2000) Glutathione S-transferase polymorphisms and colorectal cancer: a HuGE review. Am J Epidemiol 151:7-32
16. Benhamou S, Lee WJ, Alexandrie AK et al. (2002) Meta- and pooled analyses of the effects of glutathione S-transferase M1 polymorphisms and smoking on lung cancer risk. Carcinogenesis 23:1343-1350
17. Coughlin SS, Hall I.J. (2002) Glutathione S-transferase polymorphisms and risk of ovarian cancer: a HuGE review. Genet Med 4:250-257
18. Meyer DJ, Coles B, Pemble SE et al. (1991) Theta, a new class of glutathione transferases purified from rat and man. Biochem J 274:409-414
19. Thier R, Wiebel FA, Hinkel A et al. (1998) Species differences in the glutathione transferase GSTT1-1 activity towards the model substrates methyl chloride and dichloromethane in liver and kidney. Arch Toxicol 72:622-629
20. Garnier R, Rambourg-Schepens MO, Müller A, Hallier E (1996) Glutathione transferase activity and formation of macromolecular adducts in two cases of acute methyl bromide poisoning. Occ Environm Med 53:211-215
21. Chen H, Sandler DP, Taylor JA et al. (1996) Increased risk for myelodysplastic syndromes in individuals with glutathione transferase theta 1 (GSTT1) gene defect. Lancet 347:295-297
22. Atoyebi W, Kusec R, Fidler C et al. (1997) Glutathione S-transferase gene deletions in myelodysplasia. Lancet 349:1450-1451
23. Basu T, Gale RE, Langabeer S, Linch D.C. (1997) Glutathione S-transferase theta 1 (GSTT1) gene defect in myelodysplasia and acute myeloid leukaemia. Lancet 349:1450
24. Levy GN, Weber W.W. (2002) Arylamine acetyltrans-ferases. In: Ioannides C (ed) Enzyme systems that metabolise drugs and other xenobiotics. Wiley, New York Weinheim, pp 441-457
25. Grant DM, Hughes NC, Janezic SA et al. (1997) Human acetyltransferase polymorphisms. Mut Res 376:61-70
26. Cartwright RA, Glashan RW, Rogers HJ et al. (1982) Role of N-actyltransferase phenotypes in bladder carcinogenesis: a pharmacogenetic epidemiological approach to bladder cancer. Lancet II:842-846
27. Lewalter J, Mischke L.W. (1991) Empfehlungen zur arbeitsmedizinischen Prävention expositions- und dispositionsbedingter Arbeitsstoff- Beanspruchungen. Verhandlungen Dtsch Gesellschaft Arbeitsmed 31:135-139
28. Golka K, Prior V, Blaszkewicz M., Bolt H.M. (2002) The enhanced bladder cancer susceptibility of NAT2 slow acetylators towards aromatic amines: a review considering ethnic differences. Toxicol Lett 128:229-241
29. Marcus PM, Vineis P, Rothman N. (2000) NAT2 slow acetylation and bladder cancer risk a meta-analysis of 22 casecontrol studies conducted in the general population. Pharmacogenetics 10:115-122
30. Johns LE, Houlston R.S. (2000) N-acetyl transferase-2 and bladder cancer risk: a meta-analysis. Environ Mol Mutagen 36:221-227
31. Vineis P, Marinelli D, Autrup H et al. (2001) Current smoking, occupation, N-acetyltransferase-2 and bladder cancer: a pooled analysis of genotype-based studies. Cancer Epidemiol Biomarkers Prev 10:1249-1252
32. Cascorbi I, Brockmöller J, Mrozikiewicz PM et al. (1996) Homozygous rapid arylamine N-acetyltrans-ferase (NAT2) genotype as a susceptibility factor for lung cancer. Canc Res 56:3961-3966
33. Lang N.P., Chu DZ, Hunter CF et al. (1986) Role of aromatic amine acetyltransferase in human colo-rectal cancer. Arch Surg 121:1259-1261
34. Brockton N, Little J, Sharp L., Cotton S.C. (2000) N-acetyltransferase polymorphisms and colorectal cancer: a HuGE review. Am J Epidemiol 151:846-861
35. Bock KW (2002) UDP-Glucuronosyltransferases. In: Ioannides C (ed) Enzyme systems that metabolise drugs and other xenobiotics. Wiley, New York Weinheim, pp 281-318
36. Glatt H (2002) Sulphotransferases. In: Ioannides C (ed) Enzyme systems that metabolise drugs and other xenobiotics. Wiley, New York Weinheim, pp 353-439
37. Hayashi S, Watanabe J, Kawajiri K. (1992) High susceptibility to lung cancer analyzed in terms of combined genotypes of P4501A1 and mu-class glutathione S-transferase genes. Jpn J Cancer Res 83:866-870
38. Rebbeck TR (1997) Molecular epidemiology of the human glutathione S-transferase genotypes GSTM1 and GSTT1 in cancer susceptibility. Canc Epidem Biomark Prev 6:733-743
39. Vineis P, Schulte P, McMichael A.J. (2001) Misconceptions about the use of genetic tests in populations. Lancet 357:709-712
40. Rothman N, Wacholder S, Caporaso NE et al. (2001) The use of common genetic polymorphisms to enhance the epidemiologic study of environmental carcinogens. Biochim Biophys Acta 1471:C1-C10
41. Ioannidis JPA, Ntzani EE, Trikalinos T.A., Contopou-los-Ioannidis DG (2001) Replication validity of genetic association studies. Nat Genet 29:306-309
42. Garte S (2001) Metabolic susceptibility genes as cancer risk factors: time for a reassessment? Cancer Epidemiol Biomarkers Prev 10:1233-1237
43. Schulz TG, Hallier E. (1999) Die Bedeutung von genetischen Polymorphismen Fremdstoff-metaboli-sierender Enzyme in der Arbeitsmedizin. Arbeits-med Sozialmed Umweltmed 34:307-314
44. Zinke E, Morun H. (2000) Genetische Diagnostik und Arbeitsmedizin. Expertenanhörung der Enquete-Kommission "Recht und Ethik der modernen Medizin," des Deutschen Bundestages, Themengruppe 3 (Genetische Daten) 4.12.2000, Berlin
45. Schulz TG, Degen G, Foth H et al. (2002) Stellungnahme zur Bedeutung von genetischen Polymor-phismen von Fremdstoff-metabolisierenden Enzymen in der Toxikologie. Umweltmed Forsch Praxis 7:232-246
46. Degen G, Foth H, Kahl R et al. (1999) Notfallausweis Glutathion-S- Transferasen - Stellungnahme der Sektion Toxikologie der DGPT. Umweltmed Forsch Prax 4:268
47. Fabig KR (1999) Glutathion-S-Transferase T1 und Multiple Chemikaliensensitivität (MCS). Umwelt Medizin Gesellschaft 11:226-232
48. Fabig (2002) Umweltgifte ohne genetische Antwort. Umwelt Medizin Gesellschaft 15:293-300
49. Fabig KR (2003) Polymorphismen in der Umweltmedizin. Erfahrungen und Indikationen. Umwelt Medizin Gesellschaft 16:103-111
50. DFG (1999) Humangenomforschung und prädiktive genetische Diagnostik: Möglichkeiten - Grenzen - Konsequenzen. Stellungnahme der Senatskommission für Grundsatzfragen der Genforschung der DFG. Eigenverlag, Bonn
51. Anonymus (2001) Grundsätze der Bewertung von umweltmedizinischen Methoden. Bundesgesundheitsblatt 5:519-522